Feels like I bought NVAX at $7, super excited about this one. RLFTF holds the PATENT! pump, pump, pump, comon pump it up! It will take RLFTF about 6-12 months for a chance to make a 10-100x return from here if the product really takes off. 10, A Board member of RLFTF saidduring an interview that by October they will be ready to deliver treatment to 100'000 patients. I have a modest 10K share position with RLFTF and an aiming for $2 - $5 sp. Real-time trade and investing ideas on Biolase Inc. BIOL from the largest community of traders and investors. Here is to hoping it does well! Jk, I'm in the stock too and hoping any news will "send it to the moon!". I'm still holding hoping this takes off yay! Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. RLFTF is registered as RLF.SW at the Swiss Stock Exchange and is subject to swiss exchange law's and regulations. And if they can get early stage treatments available, then the sky is the limit and they could become a major player (with proper management). Rlftf is the otc ticker. Publishing of (Corporate) News is only allowed off Market (at least 90 minutes prior to Market opening) if News is published during the Market hours, trading will be suspended for some time. Analysis see the intermediate Share Price target at 18$ which would be a 3600% increase of the current Price.9, In the Upcoming Days we expect an announcement of a Partnership with a large drug distribution and logistics Company. Please contact the moderators of this subreddit if you have any questions or concerns. Please do your own due diligence prior to investment and let me know if you would like to have more information included in this Post, i'll try to update it accordingly. This Post intends to give an overview over the ticker RLFTF, it is divided in different sections to give a holistic overview over RLFTF. Real-time trade and investing ideas on Acer Therapeutics Inc. ACER from the largest community of traders and investors. I picked up 20000 shares at 16 cents. Basically, I was reading some science articles late at night, and stumbled across a publication about RLF-100. Crowd Fever Detection -Rigorous Testing Before Launch - ITT TSXV - INOTF OTC -BREAKOUT ALERT Relief Therapeutics Stock Rockets 2000% This Week: Are You Holding? 10, Study Results of the Phase 2/3 Study are due in September. It's great! Report Save. 50$ Fee for a 40$ Buy is a bit a overkill.. Fidelity does that, Etrade does not. This patients consist out of the worst case COVID-19 cases like patients with combined double lung transplant rejection and severe COVID-19 infections. 3. Compared with the existing treatments both RLFTF and CYDY have a stellar effectiveness. Relief Therapeutics own all rights on RLF-100 and pays NeuroRX to conduct the trials. 7, - There is currently a high volume of requests for Expanded Access from US licensed physicians 8, RLFTF has a FDA Fast Track designation for the RLF-100 Drug1 all clinical trials and studies are conducted by Relief Therapeutics partner NeuroRX, a privately held US Company. Quite exciting, checked out the links. Foreign OTC transaction fee. Posts about equities, options, forex, futures, analyst upgrades & downgrades, technical and fundamental analysis, and the stock market in general are all welcome. This includes beginner questions and portfolio help. When you come across RLFTF it's almost impossible to miss CYDY. 10, It is expected that the Data Monitoring Committee might Stop the study and recommend an approval to the FDA, so that Patients from the Placebo control group can be treated as well.10, Stock Exchange, Markets and Regulatory Specifics. (https://www.neurorxpharma.com/press-releases/big-rock-partners-acquisition-corp-announces-merger-with-neurorx-inc/). https://www.fda.gov/news-events/press-announcements/covid-19-update-fda-broadens-emergency-use-authorization-veklury-remdesivir-include-all-hospitalized. RLF seemingly had a very volatile few months, which is not unlikely for penny stocks. Rlfsw is the ticker for the Swiss six exchange. RLFTF is a Drug Development Company registered at the Swiss Stock Exchange RLF.SW and US OTC Ticker RLFTF. This will be HUGE if the Phase 3 Results are good which is expected to be out tomorrow due to an SEC filing today by BRPA...and the results of the trials have been awesome so far: Big Rock Partner Acquisition (BRPA) is merging with NeuroRX so that NeuroRX can list on NASDAQ. Real-time trade and investing ideas on Zomedica Pharmaceuticals Corp ZOM from the largest community of traders and investors. In this EAP aims to treat the most critical COVID-19 Patient. Phase 2/3 Trial, IV RLF-100 for Critical COVID-19 Patients, Estimated completion in September 2020 https://clinicaltrials.gov/ct2/show/NCT04311697, FDA granted IND for Clinical Trial of RLF-100 in inhaled version with the goal to provide a preventive treatment at home to prevent a moderate/severe COVID-19 infection.4 Estimated completion in November https://clinicaltrials.gov/ct2/show/NCT04360096, FDA Intermediate Population Expanded Access of RLF-100, Expanded Access Program for cases too critical to be part of the above studies. UPDATE: 14 hrs after I posted the above at market close today RLFTF is up 38% and BRPA is up 50%. It’s getting beaten to a pulp by larger competition but is due to uplist on NADAQ any day and Statistically significant results from a phase 2 mild to moderate, double blind placebo controlled trial is currently with the FDA for review. Just sayin’... (4:07 pm on 1/28/21). RLFTF's patented drug RLF-100TM(Aviptadil/VIP) has a FDA Fast Track designation and is in two Clinical Trials and a FDA Intermediate Expanded Access Program. Find the latest LIBERTY ONE LITHIUM CORP (LRTTF) stock quote, history, news and other vital information to help you with your stock trading and investing. 1 https://www.prnewswire.co.uk/news-releases/rlf-100-aviptadil-clinical-trial-showed-rapid-recovery-from-respiratory-failure-and-inhibition-of-coronavirus-replication-in-human-lung-cells-892685658.html, 2 https://www.businesswire.com/news/home/20200607005050/en/Relief-Therapeutics-NeuroRx-Expand-Clinical-Trial-RLF-100, 3 https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3665228, 4 https://www.prnewswire.co.uk/news-releases/fda-grants-inhaled-use-ind-for-rlf-100-aviptadil-to-treat-patients-with-moderate-and-severe-covid-19-aiming-to-prevent-progression-to-respiratory-failure-874341601.html, 5 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738270/, 6 https://themarket.ch/interview/relief-therapeutics-our-drug-could-generate-hundreds-of-millions-of-dollars-per-year-ld.2478, 7 https://www.neurorxpharma.com/our-services/non-us-country-rep/, 8 https://www.neurorxpharma.com/our-services/usa-licensed-physicians/, 9 https://seekingalpha.com/article/4367483-relief-therapeutics-discovers-promising-covidminus-19-killer, 10 https://www.youtube.com/watch?v=KBG_BYfj-sY. Since the announcement BRPA has skyrocketed. Looks like that $50 fee is a foreign transaction fee. CYDY's LL drug does.2, RLF-100 is a natural peptide produced and used by the body to protect & heal the lung and to improve blood oxygenation. PS: nasdaq listing requires a stock to be over 3 dollars, so not going to happen for RLFTF anytime soon and if CYDY can't stop the drop for them neither.. You think 2Billion is too much? Further RLF-100 acts on RANTES(CCL5) and could be indicated for treatment of HIV, Cancer and other RANTES specific diseases after further studies. Good input, which broker do you use? Here's an example of a medical doctor that was scheduled for a double lung transplant that started taking RLF-100 and was cured soon after...he said it was a "miracle". This RELIEF THERAPEUTICS Holding SA (stock ticker symbol: RLFTF is a good stock to invest in for treatment of Covid-19 virus. There is so much going on here...everyone should take a closer look. As noted in the initial issuance of the EUA, the emergency use of Veklury was limited to those patients with severe disease, which was defined as patients with low blood oxygen levels or needing oxygen therapy or more intensive breathing support such as a mechanical ventilator. level 1. More posts from the StockMarket community. Nokia stock jumps following rally in Reddit favorites Last Updated: Feb. 25, 2021 at 10:44 a.m. I follow the clinical development of RLF-100 since the outbreak of SARS-COV-2 and i'm invested since early spring, i see myself as a long term investor. Very interesting and thanks for putting this together. See RELIEF THERAPEUTICS HOLDING AG (RLFTF) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Market Makers are f*cked from call buying. RLFTF is a Drug Development Company registered at the Swiss Stock Exchange RLF.SW and US OTC Ticker RLFTF. • Relief is traded over the counter (OTC) on the Swiss SIX exchange. This combined with the potential of using it with an inhaler at home, makes it for me the most potent drug for COVID-19. This is huge news and why RLFTF stock is a bargain at a $1.54 billion market cap. The markets have never seen disruption like this before. RLFTF just filed a OTCQB Application and will therefor also be regulated by the SEC in the future, though i feel the Swiss Regulation is stricter anyway. So many stocks that could go up with bright futures on the horizon. Next one is Emergency Use Authorization (EUA) with the FDA very soon after! " Disagree, argue, criticize, but no personal attacks. NOTE: BRPA jumped 20% in AH today. RLFTF stock is going to be a good stock. https://clinicaltrials.gov/ct2/show/NCT04453839, All currently available Clinical Data regarding COVID-19 is from the Expanded Access. I checked their market cap, which was about 300 million at the time, and realized if they turn out to be even half as effective as their early claims, they’d end up taking almost all of the market for late stage covid treatment (probably at least 10x). In my opinion RLF-100 is superior when it comes to the treatment of COVID-19, as it acts (by pure luck for RLFTF) Anitviral and blocks the virus in it's tracks which is why it is so efficient - 90% decrease of mortality is almost unheard of and on top of that it's a natural peptide, much like insulin.. Please note that as a topic focused subreddit we have higher posting standards than much of Reddit: 1) Please direct all advice requests and beginner questions to the stickied daily threads. Do your own research as there is a lot here to look into !!! 2. 5,6, RLF-100 inhibits the SARS-COV-2(COVID19) Virus from replicating itself by blocking the respective receptors. So a bunch of traders on reddit can push a stock to its limit and unleash havoc to the tune of billions in losses for the sleaziest group of manipulators on the planet (aka hedge funds) but our ticker which has … My other holding is CYDY at 11k shares, would be interested in your perspective? The first 21 Patients showed a Rapid recovery and a mortality reduction of over 90%. Press question mark to learn the rest of the keyboard shortcuts, https://www.neurorxpharma.com/press-releases/big-rock-partners-acquisition-corp-announces-merger-with-neurorx-inc/, https://www.prnewswire.com/news-releases/relief-and-neurorx-announce-partnership-for-global-commercialization-of-rlf-100-and-selection-of-commercial-partners-301134379.html, https://wsvn.com/news/local/miami-dade/miami-beach-doctor-recovering-from-covid-19-after-taking-new-drug/, https://www.biospace.com/article/releases/neurorx-and-relief-announce-topline-efficacy-data-from-patients-treated-with-rlf-100-aviptadil-under-the-u-s-fda-expanded-access-protocol-authorization-for-respiratory-failure-related-to-critical-covid-19/. … Press question mark to learn the rest of the keyboard shortcuts, https://clinicaltrials.gov/ct2/show/NCT04311697, https://clinicaltrials.gov/ct2/show/NCT04360096, https://clinicaltrials.gov/ct2/show/NCT04453839, https://themarket.ch/interview/relief-therapeutics-our-drug-could-generate-hundreds-of-millions-of-dollars-per-year-ld.2478, https://www.prnewswire.co.uk/news-releases/rlf-100-aviptadil-clinical-trial-showed-rapid-recovery-from-respiratory-failure-and-inhibition-of-coronavirus-replication-in-human-lung-cells-892685658.html, https://www.businesswire.com/news/home/20200607005050/en/Relief-Therapeutics-NeuroRx-Expand-Clinical-Trial-RLF-100, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3665228, https://www.prnewswire.co.uk/news-releases/fda-grants-inhaled-use-ind-for-rlf-100-aviptadil-to-treat-patients-with-moderate-and-severe-covid-19-aiming-to-prevent-progression-to-respiratory-failure-874341601.html, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738270/, https://www.neurorxpharma.com/our-services/non-us-country-rep/, https://www.neurorxpharma.com/our-services/usa-licensed-physicians/, https://seekingalpha.com/article/4367483-relief-therapeutics-discovers-promising-covidminus-19-killer, https://www.youtube.com/watch?v=KBG_BYfj-sY, https://www.nejm.org/doi/full/10.1056/NEJMoa2007764, https://www.fda.gov/news-events/press-announcements/covid-19-update-fda-broadens-emergency-use-authorization-veklury-remdesivir-include-all-hospitalized. Real-time trade and investing ideas on AgEagle Aerial Systems UAVS from the largest community of traders and investors. share. I did have some CYDY shares and still think the company could have great potential, but i don't invest in companies were the management sells of massive amounts of their shares - regardless of the data and potential, it's just a show-stopper for me. I rarely invest in pennies. Should ZYESAMI be approved for emergency use by the FDA, financial projections generated in partnership with IQVIA (previously IMS) estimate potential gross sales in excess of $1.4 billion for the treatment of COVID-19 Respiratory Failure may be obtained in the United States, assuming that a successful vaccination for COVID-19 is introduced. In May 2020, the FDA issued an EUA that authorized Veklury for the treatment of hospitalized adult and pediatric patients with severe COVID-19. Welcome to /r/StockMarket! Robinhood & Reddit retail traders are armed with financial weapons of mass destruction, aka leveraged options. I don't know too much about OTC stocks … Anyway, hope you are as happy with your RLFTF shares as i am with mine. ELI5 if you can please. I harvested a few thousand shares at .70, I’ve already made my initial back, so at this point I’m just here for the ride. There is little chance with this stock for a late "jump-on" once a big catalyst is released, as it will be off-market. 3) This is an open forum but we expect you to conduct yourself like an adult. Pretty good article on CEO Michael Frank buying shares, was also posted on RVVTF community on Reddit. ET My primary investment motivation is that, after extensive reasearch over months, i believe in the potential of this drug. We have obtained leaked documents of Relief Therapeutics (OTC:RLFTF) biotech presentation scheduled for January 11 th to January 15 th.. Overview of their Biotech Presentation. Current Demand / Demand for Expanded Access, - On behalf of Relief Therapeutics, NeuroRX is currently fielding multiple requests from representatives of health ministries, who would like to access RLF-100 for their countries. This is a game changer. Public Term Search Links Google News: RLF-100,RLFTF Google Trends: RLF-100,RLFTF Twitter: RLF-100 Twitter: RLFTF Reddit: RLF-100 Reddit: RLFTF "Relief Therapeutics holds FDA orphan … Hi, welcome to r/investing. I'll repost what I said over on the RLFTF board, (on YAHOO) because if in fact YOU, Vader, are the author and not Hooter86, then you do deserve all the kudos for this. In the US RLFTF is a OTC Traded Stock. The recent pullback could offer some decent entry levels for the brave however. Excellent synopsis Doctor … I guess it can also be valuable for people invested in other COVID-19 stocks, to see what the competition does.. Judged by the Expanded Access data, which treats more severe Cases than in the Study, the results are expected to be very good. Information about Market Cap, Outstanding Shares and Expected Earnings. When they are announce positive trial results these stocks … NeuroRx is currently conducting Phase 2b/3 clinical trials, with read out data expected by January 28, 2021 " on page 173 of the BRPA SEC filing that came out today. All Management Transactions and Transactions of Significant Shareholders have to be Published according to the Swiss Exchange Regulations. 1, RLF-100 prevents and/or stops the Cytokine Storm, is highly anti-inflamantory and acts on RANTES (CCL5) - in almost the same way that e.g. ET First Published: Feb. 25, 2021 at 5:54 a.m. Violations will result in a minimum 30 and likely 60 day ban upon first instance. But in general i think the more drug's we have who can tackle COVID-19 the better. (Funded by the National Institute of Allergy and Infectious Diseases and others) https://www.nejm.org/doi/full/10.1056/NEJMoa2007764, COVID-19 Update: FDA Broadens Emergency Use Authorization for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19 For Immediate Release**:** August 28, 2020. Seeking Alpha has a great article on this as well; might as well be worth a gamble, but I'd be well prepared to lose it all, New comments cannot be posted and votes cannot be cast, Press J to jump to the feed. I did a lot of research into it and CYDY has some great potential in the HIV and Cancer treatment, though so does RLFTF - when it comes to RANTES/CCL5 they both are very very similar. (https://www.prnewswire.com/news-releases/relief-and-neurorx-announce-partnership-for-global-commercialization-of-rlf-100-and-selection-of-commercial-partners-301134379.html), RLF-100 has been showing extremely excellent results in it's trials so far, as well as it's use in Expanded Access Protocol (EAP) which allows its use in patients that cannot be part of the Phase 3 trial due to pre-existing conditions (e.g. --- OP, didn't see you mention it's also an ED droog. ... Twitter: RLFTF Reddit: RLF-100 Reddit: RLFTF … Also, if these guys make a huge profit will they go public on the NYSE potentially, and we could see another huge run up then? Shares of Relief Therapeutics (OTC:RLFTF) has gained momentum again as the company affirms Zyesami COVID-19 trial. New England Journal of Medicine: Remdesivir was superior to placebo in shortening the time to recovery in adults hospitalized with Covid-19 and evidence of lower respiratory tract infection. Our objective is to provide short and mid term trade ideas, market analysis & commentary for active traders and investors. Looks promising! I am a bot, and this action was performed automatically. I truly believe that RLF-100 is the most promising COVID-19 drug, i don't really care if anyone here invests or not and i'm generally more interested in the clinical data side than in the stock, but i thought i share some information and facts for people that already thought about investing and / or doing their own DD.. Publication indicated that it seemed to be highly effective in some COVID-19 patients on ventilators. All indications are that RLF-100 is effective and we are waiting for the next results to hit the tape. Currently there are 2 Clinical Trials underway and a FDA Intermediate Expanded Access Program. They are charging it on Charles Schwab too. This may be low but with 2 billion outstanding shares I can’t wrap my head around anything over that. (https://wsvn.com/news/local/miami-dade/miami-beach-doctor-recovering-from-covid-19-after-taking-new-drug/), " RLF-100™ therapy associated with a 9-fold increased probability of survival and recovery from respiratory failure in an open-label, prospective study " (https://www.biospace.com/article/releases/neurorx-and-relief-announce-topline-efficacy-data-from-patients-treated-with-rlf-100-aviptadil-under-the-u-s-fda-expanded-access-protocol-authorization-for-respiratory-failure-related-to-critical-covid-19/). Rlftf is at .45 but has 3 B shares BRPA is at 35 but has 700k!!! RLFTF is a Drug Development Company registered at the Swiss Stock Exchange RLF.SW and US OTC Ticker RLFTF. Today, as part of its ongoing efforts to fight COVID-19, the U.S. Food and Drug Administration broadened the scope of the existing emergency use authorization (EUA) for the drug Veklury (remdesivir) to include treatment of all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19, irrespective of their severity of disease. cancer, heart attach, lung transplant, etc.). Haha. This could be the next one !!!! It’s not beyond … RLF-100 blocks the COVID-19 Virus, prevents a cytokine storm, heals the lungs and improves blood oxygenation with a mortality reduction of over 90% in the most severe cases. RLFTF's patented drug RLF-100 TM (Aviptadil/VIP) has a FDA Fast Track designation … Find the latest AB INTL GROUP CORP (ABQQ) stock discussion in Yahoo Finance's forum. And the next catalyst after that is the inhaled form of rlf-100 which is in trials now. I bought 100 shares at 40cents per share, then got whacked with a $50 fee because I didnt read the fine print. Yeah! 6, While it is difficult to determine a Share Price for a Stock which this Potential, my personal calculations put the potential between 5-20$. ... EDIT: this turned into my involved Reddit … Technically we're looking at a sharp gap … Reply. Together with it’s partner NeuroRx, these companies have breakthrough treatments for the COVID-19 coronavirus. NeuroRx, Inc. and RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief"), and the Quantum Leap Healthcare Collaborative ("Quantum Leap") of San Francisco announce that NeuroRx … They are also working on an inhaled version. And considering every other drug is basically not effective at that point, and the few that are effective only seem to work very early on in the disease’s progression - it seemed like a no brainer. Their drug worked so well on critically ill patients they decided to try it in an inhaled form to prevent covid 19 patients from going critical. 2 comments Over the course of the past months, companies working on coronavirus medicines or vaccines have seen their stocks … Real-time trade and investing ideas on Vaxart Inc VXRT from the largest community of traders and investors. ", https://www.sec.gov/Archives/edgar/data/1719406/000119312521019278/d56937ds4.htm. RLFTF's patented drug RLF-100 TM (Aviptadil/VIP) has a FDA Fast Track … Our first VIP-derived product - ZYESAMI (RLF-100), the NeuroRx COVID-19 Drug - was awarded Fast Track designation by the FDA in June 2020 and admitted to the Coronavirus Treatment Acceleration Program. There was a very comprehensive interview by a Swiss Investment Newspaper covering the Above topics, please check out https://themarket.ch/interview/relief-therapeutics-our-drug-could-generate-hundreds-of-millions-of-dollars-per-year-ld.2478 , it contains almost everything we want to know at this Point. Relief Therapeutics' RLF-100 can reduce hospital stay due to COVID-19 Seeking Alpha - 2/10/2021 6:49:43 AM: Relief initiates phase 2/3 trial of inhaled RLF-100 in severe COVID-19 Seeking Alpha - 2/8/2021 … RLFTF Stock… Same! Severe CASES of COVID-19 have shown low levels of exactly this Peptide.3. STOCK / COMPANY • Relief Therapeutics is a small company in Switzerland that holds the patent on RLF-100. All quotes are in local exchange time. Figured that was worth a small gamble. Here's the excerpt and found on page 240: " NeuroRx’s research programs beyond 2021 would require additional funding either from sales of product or from external investment. And considering every other drug is basically not effective at that point, and the few that are effective only seem to work very early on in the disease’s progression - it seemed like a no brainer. In the absence of a successful vaccination or should viral mutation degrade the immunity afforded by existing vaccinations, revenues could be higher. Let me make this as brief as possible (and anyone please provide more details, corrections, references).
Marondera Zimbabwe Map, Cheap Flights To Great Barrier Reef, Ukulele For Beginners Uk, Ancient Probiotics Gut Restore Reviews, Garmin Delta Sport Xc, Standard Bank Rosebank, Eastleigh Borough Council Food Waste, Intranatal Nursing Care Plan Slideshare,